Arun Kumar, founder and group chief executive officer of Strides Arcolab Limited - a first generation, Indian pharmaceutical company headquartered in Bengaluru - is preparing for a crucial meeting of the Board of Directors.
The assembly was called to talk about the proposed dividend payout to the business 's stockholders following the end of a US$1.725 billion sale of its specialty department - Agila Specialties - to the U.S.-based pharmaceutical company Mylan Inc. Kumar proposed that Strides distribute all the free cash available from the sale - after the retirement of debt and internal payouts - in the kind of dividends to its stockholders. Strides had conveyed its decision to retire debts and reduce its influence. Tulsi Jayakumar is affiliated with SP Jain Institute of Research & Management.
Strides Arcolab Limited's Dividend Pay-Out Decision case study solution
PUBLICATION DATE: July 22, 2015 PRODUCT #: W15317-HCB-ENG
This is just an excerpt. This case is about FINANCE & ACCOUNTING
Related Case Solutions & Analyses:
Quality Imaging Products (QIP)
E-Loan: The CarFinance.com Acquisition
Telewizja Wisla
Toronto-Dominion Bank — Money Monitor
Compania de Telefonos de Chile
Capital Assets Pricing Model
Financial Risk Management
Note on Budget Ploys
Shady Trial
Societe International de Plantations et de Finance (SIPEF)
